RO — Roche Holding AG Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Roche Holding AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	58,323	62,801	63,281	58,716	60,495
Cost of Revenue
Gross Profit	42,423	43,453	44,651	43,209	44,775
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	39,794	44,666	45,875	43,555	47,241
Operating Profit	18,529	18,135	17,406	15,161	13,254
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	17,965	17,398	16,327	14,079	11,793
Provision for Income Taxes
Net Income After Taxes	15,068	14,935	13,531	12,358	9,187
Minority Interest
Net Income Before Extraordinary Items
Net Income	14,295	13,930	12,421	11,498	8,277
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	14,294	13,929	12,420	11,498	8,277
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	17	16.6	17.9	18.7	17.7
Dividends per Share